DOCSLIB.ORG

Hugo De Jonge Dutch Minister of Health, Welfare and Sport Talks About a More Dementia- Friendly Netherlands

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Hugo De Jonge Dutch Minister of Health, Welfare and Sport Talks About a More Dementia- Friendly Netherlands Issue 31 October 2019 Hugo de Jonge Dutch Minister of Health, Welfare and Sport talks about a more dementia- friendly Netherlands Gerjoke Wilmink Debbie Abrahams MP Ellý Katrín Guðmundsdóttir Alzheimer Nederland Executive Director discusses findings of UK inquiry into how people Chairperson of Iceland’s new dementia working reflects on the organisation’s 35 years with dementia are treated, compared with others group talks about what the group means to her supporting people with dementia with disabilities TABLE OF CONTENTS Contents 3 Welcome Contact by Iva Holmerová, Chairperson of Alzheimer Europe Alzheimer Europe 14, rue Dicks L-1417 Luxembourg Alzheimer Europe +352 29 79 70 +352 29 79 72 4 Engaging with members of the European Alzheimer’s Alliance www.alzheimer-europe.org 5 Our involvement in two new projects: AD Detect and Prevent, and VirtualBrainCloud [email protected] 9 Making dementia services and support culturally appropriate @AlzheimerEurope alzheimer.europe Policy Watch 13 Who’s who in the EU? 19 Governmental Expert Group on Dementia discusses national policy developments 22 Data-sharing in dementia research Board 25 Slovenian Prime Minister addresses neurological diseases conference Chairperson: Iva Holmerová (Czech Republic) Vice-Chairperson: Charles Scerri (Malta) Dementia in Society Honorary Secretary: Jim Pearson (UK – Scotland) Honorary Treasurer: Maria do Rosário Zincke 27 Examining the real impact of dementia policy campaigns dos Reis (Portugal) 30 UK inquiry looks at societal barriers for people with dementia Members Helen Rochford-Brennan, Chairperson of 32 Iceland forms a working group of people with dementia the European Working Group of People with Dementia (Ireland) 35 Exploring gene therapy for Alzheimer’s disease Stefanie Becker (Switzerland) Marco Blom (Netherlands) Spotlight on the Netherlands Sabine Jansen (Germany) Pat McLoughlin (Ireland) Sirpa Pietikäinen (Finland) 37 Alzheimer Nederland celebrates 35 years helping people with dementia Jesús Rodrigo (Spain) 41 “Dementia Event” organised for and by people with dementia Karin Westerlund (Sweden) 43 Dutch Health Minister discusses a more dementia-friendly Netherlands Staff Jean Georges, Executive Director 45 Refl ecting on the Deltaplan Dementie Christophe Bintener, Project Offi cer Cindy Birck, Project Offi cer Kate Boor Ellis, Communications Offi cer Angela Bradshaw, Project Offi cer Ana Diaz, Project Offi cer Dianne Gove, Director for Projects Gwladys Guillory, Event and Conference Coordinator Owen Miller, Policy Offi cer Aideen O’Brien, Administrative Assistant Stefanie Peulen, Finance Offi cer Grazia Tomasini, Administrative Assistant Photo credits Morgunblaðið (Iceland) Tadej Bernik (Slovenia) Council of Europe European Commission European Parliament Innovative Medicines Initiative Ministry of Health, Welfare and Sport (Netherlands) 2 Dementia in Europe Layout: The Publishing Bureau WELCOME Welcome the European Parliament elections in May We then turn our attention to Iceland, where 2019 and the appointment of key Commis- a new working group of people with demen- sioners for the next fi ve years. It also includes tia was formed at the start of the year. I an update on the Governmental Expert Group would like to congratulate our colleagues on Dementia, which met for the second time at Alzheimer Iceland for convening this in June 2019. The meeting was attended by group and thank them for paying tribute to representatives from 20 European coun- Alzheimer Europe’s European Working Group tries, as well as work package leads from of People with Dementia (EWGPWD), which the 2nd European Joint Action on Dementia they say was the inspiration for the Icelandic and representatives from the World Health group. You can read about the group’s aims Organization (WHO). Conversations focused and progress made so far. Last but not least, on timely diagnosis and post-diagnostic sup- two of my Alzheimer Europe colleagues, pro- Iva Holmerová, Chairperson of Alzheimer Europe port, care coordination, residential care and ject offi cers Angela Bradshaw and Cindy Birck, dementia-friendly communities. It is truly have put together a discussion piece on gene I am pleased to welcome you to the 31st edi- heartening to see the willingness of so many therapy for Alzheimer’s disease (AD). Readers tion of Dementia in Europe – the Alzheimer countries to use this important platform to can fi nd out more about what gene therapy Europe magazine. exchange knowledge and expertise. is, and whether or not it might be useful in the future treatment of AD. The fi rst section of our magazine highlights We then take a look at the ins-and-outs of some of our efforts to ensure dementia data-sharing in clinical research projects. Our fi nal section shines a spotlight on the remains a European priority. It begins with an The work we are doing in this area, which Netherlands and on Alzheimer Nederland, update on progress in reconvening the new will be published at the end of 2019, is made examining the excellent work taking place in European Alzheimer’s Alliance, the non-ex- possible thanks to a grant from Gates Ven- the country. Alzheimer Nederland is co-host- clusive, multinational and cross-party group tures. Our policy section concludes with a ing our 29th Alzheimer Europe Conference that brings together Members of the Euro- piece about the policy outcomes of a recent “Making valuable connections” (#29AEC) in pean Parliament (MEPs) to support Alzheimer Spominčica (Alzheimer Slovenia) conference, The Hague. As well as looking at the his- Europe and its members to make dementia “In the Rhythm of the Human Brain”, held in tory and work of our co-hosts, this section a policy priority in Europe. This section also Ljubljana earlier this year under the honor- includes an interview with people living highlights some of the work to engage with ary patronage of Prime Minister Marjan Šarec, with dementia, who share their refl ections MEPs as the new parliamentary term com- who was a keynote speaker. following the “Dementia Event ” – a national mences and the political agenda for the next gathering for and by people with dementia. fi ve years is shaped. Our third section, Dementia in Society, Finally, we are delighted to have an interview begins with a piece about policy cam- with the Dutch Health Minister, as well as an We are pleased to present two new EU-funded paigning at local and national levels. Two of update on the country’s national dementia projects in which we are actively involved, Alzheimer Europe’s national members asso- strategy – the Deltaplan Dementie . Alzheimer’s Disease Detect and Prevent and ciations, The Alzheimer Society of Ireland VirtualBrainCloud. This fi rst section concludes and Muistiliitto – Alzheimer Society of Fin- If you are reading this magazine at our con- with an in-depth look at our ethics report on land, highlight the impact such campaigns ference, I warmly welcome you to The Hague. making services and support for people with can have in terms of concrete outcomes. dementia appropriate for people from all eth- Next, Debbie Abrahams MP, Co-chair of the Happy reading! nic communities. The work for this report was UK Government’s All Party Parliamentary carried out by an expert working group set Group (APPG) on Dementia, reveals some of up by Alzheimer Europe last year. the key fi ndings of the group’s report, “Hid- den no more: Dementia and disability”. The The Policy Watch section presents a “who’s report highlights the fact that people with who” of some of the key leaders and deci- dementia are treated diff erently to those sion-makers in the European Union following with other health conditions or disabilities. Dementia in Europe 3 ALZHEIMER EUROPE y Employment and Social Affairs commit- Engaging with European tee (EMPL) – Eight EAA members sit on this committee y Environment, Public Health and Food Alzheimer’s Alliance Safety committee (ENVI) – Eight EAA mem- bers sit on this committee members to make dementia y Industry, Research and Energy commit- tee (ITRE) – Ten EAA members sit on this a European Priority committee y Internal Market and Consumer Protection With the European Parliament now sitting for the new committee (IMCO) – Seven EAA members term (2019–2024), Alzheimer Europe has been working to sit on this committee. re-establish the European Alzheimer’s Alliance. Having these connections will allow Alzheimer Europe to better engage with decision-makers within the parliament, par- their countries. These letters highlighted the ticularly when seeking to influence legislation importance of treating dementia as an area at the committee stages. of priority, including within the Horizon 2020/ Europe research programmes, the European Pil- EAA Chair and Vice Chairs lar of Social Rights and the Health Programme. Following the European elections in May 2019, The letters also contained four specific asks: As we announced in Dementia in Europe 30 Alzheimer Europe has been working with its (June 2019), Sirpa Pietikäinen MEP (Finland) members to ensure that dementia remains a y Raise a question during hearings of can- has agreed to become the chair of the EAA priority at a European level. This work builds didates for the Council of Commissioners, in the year ahead. To ensure that we have a on the foundations laid during the #Demen- asking how they will ensure dementia is balance of representation across the political tiaPledge2019 campaign, in which we asked prioritised within their remit. spectrum, Alzheimer Europe has also written candidates to commit to joining the Euro- y Ensure that dementia is considered dur- to EAA pledgees from the EPP, S&D, Reform pean Alzheimer’s Alliance (EAA) and working ing the course of the work of the European Europe, the EFA/Greens and GUE/NGL invit- with us if elected. Parliament committees on which they sit. ing them to become Vice Chairs of the group. y Engage with their country’s national Once confirmed, Alzheimer Europe will post As a result of this campaign, the EAA now has Alzheimer’s/dementia organisation to find the details of the full make-up of the group 91 members and we are working to ensure out what is happening in their country, on its website.
Load more

Recommended publications
  • Clinical Research
    Clinical research The discovery of Alzheimer’s disease Hanns Hippius, MD; Gabriele Neundörfer, MD T he 37th Meeting of South-West German Psychiatrists (37 Versammlung Südwestdeutscher Irrenärzte) was held in Tübingen on November 3, 1906. At the meeting, Alois Alzheimer (Figure 1), who was a lecturer (Privatdozent) at the Munich University Hospital and a coworker of Emil Kraepelin, reported on an unusual case study involving a “peculiar severe disease process of the cerebral cortex” (Über einen eigenartigen, schweren Erkrankungsprozeß der Hirnrinde). Prelude On November 3, 1906, a clinical psychiatrist and neuro- anatomist, Alois Alzheimer, reported “A peculiar severe Alzheimer described the long-term study of the female disease process of the cerebral cortex” to the 37th patient Auguste D., whom he had observed and investi- Meeting of South-West German Psychiatrists in Tübingen. gated at the Frankfurt Psychiatric Hospital in November He described a 50-year-old woman whom he had fol- 1901, when he was a senior assistant there.Alzheimer had lowed from her admission for paranoia, progressive sleep been interested in the symptomatology, progression, and and memory disturbance, aggression, and confusion, until course of the illness of Auguste D. from the time of her her death 5 years later. His report noted distinctive admission, and he documented the development of her plaques and neurofibrillary tangles in the brain histology. unusual disease very precisely from the beginning. It excited little interest despite an enthusiastic response In March 1901, the husband of the 50-year-old woman had from Kraepelin, who promptly included “Alzheimer’s dis- noticed an untreatable paranoid symptomatology in his ease” in the 8th edition of his text Psychiatrie in 1910.
    [Show full text]
  • Original Nicolás Achúcarro and the Histopathology of Rabies: A
    Original Neurosciences and History 2019; 7(4): 122-136 Nicolás Achúcarro and the histopathology of rabies: a historical invitation from Nissl and Alzheimer D. Ezpeleta1, F. Morales2, S. Giménez-Roldán3 1Department of Neurology. Hospital Universitario Quirónsalud Madrid, Madrid, Spain. 2Department of Neurology. Hospital Clínico Universitario Lozano Blesa, Facultad de Medicina, Zaragoza, Spain. 3Department of Neurology. Hospital General Universitario Gregorio Marañón, Madrid, Spain. ABSTRACT Introduction. Nicolás Achúcarro (1880-1918), a brilliant disciple of Cajal, was invited by Nissl and Alzheimer to write on the subject of experimental rabies. The chapter, published in 1909 in German, has never previously been translated into Spanish. Material and methods. The study “On the understanding of the central nervous system histological pathology in rabies” was obtained from the University of Bonn, Germany, and translated into Spanish by one of the authors (FM). We researched the context of the study; its relevance to the epidemiology, diagnosis, and histopathology of rabies encephalitis; and its influence on Achúcarro’ s scientific career. Results. The study was conducted in rabbits, a dog, two hens, and a brain specimen from a man who died due to rabies. It was presented as a doctoral thesis in Madrid in December 1906. The German-language publication, from 1909, comprises 51 dense pages of text with 13 illustrations; a summary in Spanish was published in 1914. Achúcarro rejected the idea that Negri bodies were parasites, confirming Cajal’ s observations on Alzheimer neurofibrillary degeneration and argyrophilic fibres in rabies. He underlines the transformation of glial cells in the cornu ammonis into elongated elements (rod-like cells or Stäbchenzellen) to adapt to the parallel arrangement of pyramidal cells in the stratum radiatum.
    [Show full text]
  • Erop of Eronder
    TRIBUNENieuwsblad van de SP • jaargang 56 • nr. 9 • oktober 2020 • € 1,75 • www.sp.nl KERMIS EROP OF ERONDER NERTSENFOKKERS MAKEN HET BONT REFERENDUM DICHTERBIJ STEM VOOR DE KOOLMEESCUP Wéér dreigen pensioenkortingen en premiestijgingen. Maar de pensioen- bestuurders graaien lekker door uit de pensioenpot. Stemt u mee op een van deze grootverdieners? De ‘winnaar’ krijgt de Koolmeescup, genoemd naar de D66-minister die het allemaal maar toelaat. doemee.sp.nl/pensioengraaiers BEN JIJ EEN JONGE SP’ER, MAAR GEEN ROOD-LID? SLUIT JE NU GRATIS AAN EN STEUN DE MEEST ACTIEVE POLITIEKE JONGEREN ORGANISATIE VAN NEDERLAND! KOM BIJ HET LEDENTEAM! ROOD zoekt enthousiaste, praatgrage en behulpzame ROOD-leden voor het nieuwe Ledenteam. Dat zal vragen van (nieuwe) leden gaan Wil jij in het Ledenteam beantwoorden, zoals: wat doet ROOD; hoe en waar kan ik actief om de organisatie van worden; hoe draai ik mee in de SP en waar ga ik naartoe met mijn ideeën? We hopen met het Ledenteam een communicatie-snelweg ROOD te versterken? te creëren. Ook kan het Ledenteam ledenonderzoeken opzetten en een grote rol gaan spelen bij het verstrekken van informatie bij campagnes en acties. Uiteraard bieden we daarbij ondersteuning vanuit het bestuur, we willen bijvoorbeeld investeren in Ledenteam- Stuur dan jouw motivatie telefoons. Zo kunnen ook leden die graag actief willen worden maar naar [email protected] bijvoorbeeld geen ROOD-groep in de buurt hebben, zich inzetten voor ROOD. DE SP ZET ZICH IN VOOR MENSELIJKE WAARDIGHEID, GELIJKWAARDIGHEID EN SOLIDARITEIT TRIBUNE IS EEN Redactie
    [Show full text]
  • Tien Jaar Premier Mark Rutte
    Rapport TIEN JAAR PREMIER MARK RUTTE In opdracht van Trouw 8 oktober 2020 www.ioresearch.nl Colofon Uitgave I&O Research Piet Heinkade 55 1019 GM Amsterdam Rapportnummer 2020/173 Datum oktober 2020 Auteurs Peter Kanne Milan Driessen Het overnemen uit deze publicatie is toegestaan, mits I&O Research en Trouw als bron duidelijk worden vermeld. Coronabeleid: Tien jaar premier Mark Rutte 2 van 38 Inhoudsopgave Belangrijkste uitkomsten _____________________________________________________________________ 5 1 Zetelpeiling en stemmotieven _______________________________________________________ 8 1.1 Zetelpeiling _____________________________________ 8 1.2 Stemmotieven algemeen ______________________________ 9 1.3 Stemmotieven VVD-kiezers: Rutte wérd de stemmentrekker _________ 10 1.4 Stemmen op Rutte? _________________________________ 11 1.5 Redenen om wel of niet op Mark Rutte te stemmen _______________ 12 2 Bekendheid en waardering politici __________________________________________________ 13 2.1 Bekendheid politici _________________________________ 13 2.2 Waardering politici _________________________________ 14 3 De afgelopen 10 jaar ________________________________________________________________ 15 3.1 Nederlandse burger beter af na 10 jaar Rutte? __________________ 15 3.2 Polarisatie toegenomen; solidariteit afgenomen ________________ 15 4 Premier Mark Rutte _________________________________________________________________ 17 4.1 Zes op tien vinden dat Rutte het goed heeft gedaan als premier ________ 17 4.2 Ruttes “grootste verdienste”:
    [Show full text]
  • Alzheimer's 100Th Anniversary of Death and His Contribution to A
    DOI: 10.1590/0004-282X20140207 HISTORICAL NOTES Alzheimer’s 100th anniversary of death and his contribution to a better understanding of Senile dementia O 100o aniversário de morte de Alzheimer e sua contribuição para uma melhor compreensão da Demência senil Eliasz Engelhardt1,2, Marleide da Mota Gomes3 ABSTRACT Initially the trajectory of the historical forerunners and conceptions of senile dementia are briefly presented, being highlighted the name of Alois Alzheimer who provided clinical and neuropathological indicators to differentiate a group of patients with Senile dementia. Alzheimer’s examination of Auguste D’s case, studied by him with Bielschowsky’s silver impregnation technique, permitted to identify a pathological marker, the intraneuronal neurofibrillary tangles, characterizing a new disease later named after him by Kraepelin – Alzheimer’s disease. Over the time this disorder became one of the most important degenerative dementing disease, reaching nowadays a status that may be considered as epidemic. Keywords: dementia, Senile dementia, hystory of medicine, Alzheimer, Alzheimer’ disease. RESUMO Incialmente é apresentada brevemente a trajetória histórica dos precursores e dos conceitos da demência senil, sendo destacado o nome de Alois Alzheimer que forneceu indicadores clínicos e neuropatológicos para diferenciar um grupo de pacientes com Demência senil. O exame de Alzheimer do caso de Auguste D, estudado por ele com a técnica de impregnação argêntica de Bielschowsky, permitiu identificar um marcador patológico, os emaranhados neurofibrilares intraneuronais, caracterizando uma nova doença, mais tarde denominada com seu nome por Kraepelin – doença de Alzheimer. Com o passar do tempo esta desordem tornou-se uma das mais importantes doenças demenciante degenerativa, alcançando, na atualidade, um status que pode ser considerado como epidêmico.
    [Show full text]
  • History of Alzheimer's Disease
    Print ISSN 1738-1495 / On-line ISSN 2384-0757 Dement Neurocogn Disord 2016;15(4):115-121 / https://doi.org/10.12779/dnd.2016.15.4.115 DND REVIEW History of Alzheimer’s Disease Hyun Duk Yang,1,2 Do Han Kim,1 Sang Bong Lee,3 Linn Derg Young,2,4,5 1Harvard Neurology Clinic, Yongin, Korea 2Brainwise Co. Ltd., Yongin, Korea 3Barun Lab Inc., Yongin, Korea 4Department of Business Administration, Cheongju University, Cheongju, Korea 5Boston Research Institute for Medical Policy, Yongin, Korea As modern society ages rapidly, the number of people with dementia is sharply increasing. Direct medical costs and indirect social costs for dementia patients are also increasing exponentially. However, the lack of social awareness about dementia results in difficulties to dementia patients and their families. So, understanding dementia is the first step to remove or reduce the stigma of dementia patients and promote the health of our community. Alzheimer’s disease is the most common form of dementia. The term, ‘Alzheimer’s disease’ has been used for over 100 years since first used in 1910. With the remarkable growth of science and medical technologies, the techniques for diagnosis and treat- ment of dementia have also improved. Although the effects of the current symptomatic therapy are still limited, dramatic improvement is ex- pected in the future through the continued research on disease modifying strategies at the earlier stage of disease. It is important to look at the past to understand the present and obtain an insight into the future. In this article, we review the etymology and history of dementia and pre- vious modes of recognizing dementia.
    [Show full text]
  • 1 Korbinian Brodmann's Scientific Profile, and Academic Works
    BRAIN and NERVE 69 (4)：301-312，2017 Topics Korbinian Brodmann’s scientific profile, and academic works Mitsuru Kawamura Honorary Director, Okusawa Hospital & Clinics, 2-11-11, Okusawa, Setagaya-ku, Tokyo, 1580083, Japan E-mail: [email protected] Abstract Brodmann’s classic maps of localisation in cerebral cortex are both well known and of current value. However, his original 1909 monograph is not widely read by neurologists. Furthermore, he reproduced his maps in 1910 and 1914 with a number of important changes. The 1914 version also excludes areas 12-16 and 48-51 in human brain while areas 1-52 are described in animal brain. Here, we provide a detailed explanation of the different versions, and review Brodmann's academic profile and work. Key words: Brodmann’s map; missing numbers; Brodmann’s profile; Brodmann’s works; infographics Introduction The following paper is based on a Japanese language version (BRAIN and NERVE, April 2017) by MK. Recently I developed a passion for the design of charts and diagrams and enjoy looking through books on infographics. The design of visual information has made remarkable progress in recent years. Furthermore, figures, tables, and graphic records are on the agenda at every editorial meeting of Brain And Nerve. The maps of Korbinian Brodmann (1868-1918) were first published in German in 19091, and I believe they rightly belongs to infographics since they localise neuroanatomical information onto human and animal brain – monkey, for example – using the techniques of histology and comparative anatomy. Unlike the cerebellar cortex, which has a generally uniform three-layer structure throughout, most of the cerebral cortex has a six-layer structure of regionally diverse patterns.
    [Show full text]
  • The Tangled Story of Alois Alzheimer
    Bratisl Lek Listy 2006; 107 (910): 343345 343 TOPICAL REVIEW The tangled story of Alois Alzheimer Zilka N, Novak M Institute of Neuroimmunology, AD Centre of Excellence, Slovak Academy of Sciences, Bratislava, Slovakia. [email protected] Abstract In 1907, Bavarian psychiatrist Alois Alzheimer, who is considered to be a founding father of neuropa- thology, was first to describe the main neuropathologic characteristics of the peculiar disease in the brain of a woman showing progressive dementia when she was in her early 50s. Using a newly deve- loped Bielschowskys silver staining method, Alzheimer observed degenerating neurons with bundles of fibrils (neurofibrillary tangles) and miliary foci of silver-staining deposits scattered over the cortex (senile plaques). In 1910 Emil Kraepelin (Alois Alzheimers superior) coined the term Alzheimers disease to distinguish the presenile form of dementia from the more common senile variant. Alzheimers findings were followed up, and soon a number of reports of similar cases appeared in the literature. During the time, both pathological hallmarks of Alzheimers disease became the gold standard for post-mortem diagnosis of the disease. One hundred years later, dementia of Alzheimers type is con- sidered to be one of the most devastating illnesses of old age. Despite intensive research the cause of the disease still remains elusive (Fig. 2, Ref. 17). Key words: Alzheimers disease, Alois Alzheimer, Augusta D, neurofibrillary tangles, senile plaques. Alois Alzheimer was born in June 14, 1864 in Markbreit am pathology of the nervous system, studying in particular the nor- Main in Southern Germany. He commenced the study of medi- mal and pathological anatomy of the cerebral cortex.
    [Show full text]
  • Derde Kamer Handboek Politiek 1 Handleiding
    Handboek Politiek 1 Handleiding Prinsjesdag 2 Verkiezingen 7 De baas in nederland 4 Democratie 9 Thema 1 - voor de leerling Prinsjesdag 1. Bekijk filmpje 1: Prinsjesdag. Ga naar derdekamer.nl > Filmpjes > Filmpjes bij het lespakket 1 Derde Kamer Handboek politiek deel 1: Prinsjesdag (5.28 min) 2. Ga nu naar derdekamer.nl > Lesmateriaal > Download lespakket > Handboek 1 invulbaar (april 2020) handboek 1 Ga naar thema 1 – Prinsjesdag blz. 6 3. Je hebt nu 15 minuten de tijd om opdracht 1 t/m 8 van thema 1 in het Handboek Politiek te maken. (het onderdeel In debat vervalt inclusief de vragen hierover) 4. Nu kun je zelf of door iemand anders je antwoorden nakijken. 2 Thema 1 - nakijkblad met antwoorden Prinsjesdag 1. Waarom denk je dat het ‘de troonrede’ heet? Omdat de koning op een troon zit terwijl hij het voorleest. 2. Wie schrijft de tekst van de troonrede? | De koning z De minister-president 3. Kruis op de foto het gebouw aan waar de koning de troonrede voorleest. Leerlingen kruisen de Ridderzaal aan. 4. Hoe heet dit gebouw? De Ridderzaal Bonus Weet je ook hoe de andere gebouwen heten? Links op de foto is de Eerste Kamer te zien. Rechts op de foto is een deel van de Tweede Kamer te zien. 5. Wat wil dat zeggen, volksvertegenwoordiging? Dat is een groep mensen die gekozen is door de inwoners van het land, en die namens hen beslissingen neemt. 6. Hoeveel mensen herken je op onderstaande foto? Schrijf ook hun namen op als je deze weet. Eigen antwoord. Leerlingen kunnen de naam van de koning, van de minister-president en van de andere ministers noemen.
    [Show full text]
  • Rutte III in 1 Oogopslag
    Rutte III in 1 oogopslag HALBE ZIJLSTRA, VVD SIGRID KAAG, D66 1e kamer 2e kamer FERDINAND GRAPPERHAUS, CDA SANDER DEKKER, VVD 38/75 76/150 Minister van Minister voor Buitenlandse Handel Minister van Justitie en Veiligheid Minister voor Buitenlandse Zaken en Ontwikkelings samenwerking Rechtsbescherming STAS: Mark Harbers, VVD Opvang vluchtelingen in de regio INGRID VAN ENGELSHOVEN, D66 ARIE SLOB, CU Meer blauw op straat Minister van Onderwijs, Minister voor Basis- en Voort- Cultuur en Wetenschappen gezet Onderwijs en Media WOPKE HOEKSTRA, CDA ANK BIJLEVELD, CDA Verlagen werkdruk leerkrachten Minister van Financiën Minister van Defensie STAS: Menno Snel, D66 STAS: Barbara Visser, VVD BTW van 6 naar 9% Meer materieel en inzetbaarheid WOUTER KOOLMEES, D66 ERIC WIEBES, VVD Minister van Sociale Zaken en Werkgelegenheid Minister van Economische Zaken en Klimaat STAS: Tamara van Ark, VVD STAS: Mona Keijzer, CDA Versoepelen ontslagrecht, vernieuwen pensioenstelsel Op naar Parijs CAROLA SCHOUTEN, CU CORA VAN NIEUWENHUIZEN, VVD Minister van Landbouw, Minister van Infrastructuur & Natuur en Voedselkwaliteit Waterstaat & viceminister-president STAS: Stientje van Veldhoven, D66 Terugdringen gezondheids­ risico’s door veestapel Nieuwe auto’s emissieloos in 2030 MARK RUTTE, VVD KAJSA OLLONGREN, D66 Minister- HUGO DE JONGE, CDA BRUNO BRUINS, VVD president, Minister van Binnenlandse Zaken en Konin- Minister van Minister van Volksgezondheid, Wel- Minister voor krijksrelaties & vice minister-president Algemene zijn en Sport & viceminister -president Medische Zorg Zaken STAS: Raymond Knops, CDA STAS: Paul Blokhuis, CU Modernisering basisregistratie personen Eigen risico bevriezen, investeren verpleeghuiszorg STAS = Staatssecretaris VVD CDA D66 CHRISTEN UNIE.
    [Show full text]
  • Aivd Kerstpuzzel 2018
    Uitwerkingen 2018 Goed gevonden, helaas geen hints hier... AIVD KERSTPUZZEL 2018 AIVD KERSTPUZZEL AIVD KERSTPUZZEL AIVD KERSTPUZZEL ^1 Kerstpuzzel 0x7E2 h1 Opgave 1 (1)a. Wat staat hier? (2)b. Wat staat hier? (3)c. Wat staat hier? Antwoord Opgave 1 a. T L I E P T E G E N H E T N I E U W E J A A R @1 @1 @1 Kerstpuzzel 0x7E2 T1 b. V O O R W I E G R A A G Z I J N L I C H T L A A T S C H I J N E N O V E R M O E I L I J K E P R O B L E M E N c. L W W Z P Q D M B P F G O O I V B P P G R D M Z M V D Q Q O E B O D I V L 2 M E N M R C T Q R H E T B I I V A M V P O S N I S I T M V L E M E T M E E M Z D Q M Z B J D F R Z I E N U M V Q V Z C U J P 0 A T I V L S M Z W J O P A B U Q A W X H M O M J D F D M V R I V C I Z Q U C P W J 8 1 Na ontcijfering: het is Caesarversleuteling.
    [Show full text]
  • Franz Nissl (1860-1919), Noted Neuropsychiatrist and Neuropathologist, Staining the Neuron, but Not Limiting It
    Dement Neuropsychol 2019 September;13(3):352-355 History Note http://dx.doi.org/10.1590/1980-57642018dn13-030014 Franz Nissl (1860-1919), noted neuropsychiatrist and neuropathologist, staining the neuron, but not limiting it Marleide da Mota Gomes1 ABSTRACT. Franz Alexander Nissl carried out studies on mental and nervous disorders, as a clinician, but mainly as a pathologist, probably the most important of his time. He recognized changes in glial cells, blood elements, blood vessels and brain tissue in general, achieving this by using a special blue stain he himself developed – Nissl staining, while still a medical student. However, he did not accept the neuron theory supported by the new staining methods developed by Camillo Golgi and Santiago Ramón y Cajal. Nissl had worked with the crème de la crème of German neuropsychiatry, including Alois Alzheimer, besides Emil Kraepelin, Korbinian Brodmann and Walther Spielmeyer. He became (1904), Kraepelin’s successor as Professor of Psychiatry and Director of the Psychiatric Clinic, in Heidelberg. Moreover, in 1918, the year before Nissl´s death, Kraepelin offered him a research position as head of the Histopathology Department of the newly founded “Deutsche Forschungsanstalt fur Psychiatrie” of the Max Planck Institute for Psychiatry, in Munich. Key words: Franz Nissl, neuropathology, staining method, neuron theory. FRANZ NISSL (1860-1919), NOTÁVEL NEUROPSIQUIATRA E NEUROPATOLOGISTA, TINGINDO O NEURÔNIO, MAS NÃO O LIMITANDO RESUMO. Franz Alexander Nissl realizou estudos sobre transtornos mentais e nervosos, como clínico, mas principalmente como patologista, provavelmente o mais importante de seu tempo. Ele reconheceu mudanças nas células gliais, elementos sangüíneos, vasos sangüíneos e tecido cerebral em geral, realizando-o por meio de um corante azul especial desenvolvida por ele mesmo – coloração de Nissl, ainda como estudante de medicina.
    [Show full text]